Search

Your search keyword '"Avitabile, Emma"' showing total 33 results

Search Constraints

Start Over You searched for: Author "Avitabile, Emma" Remove constraint Author: "Avitabile, Emma" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
33 results on '"Avitabile, Emma"'

Search Results

1. Liver fibrosis screening increases alcohol abstinence

2. Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis

3. Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular Profiling

4. Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients

5. Adding Inflammatory Markers and Refining National Institute on Alcohol Abuse and Alcoholism Criteria Improve Diagnostic Accuracy for Alcohol-associated Hepatitis

6. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis

8. OS-005-YI Single-cell RNA sequencing analysis in alcohol-related liver disease identifies specific cell subpopulations characterized by an inflammatory profile in alcohol-associated hepatitis

9. Patients with alcohol-related cirrhosis who recompensate on follow-up have a characteristic metabolomic profile with differential concentrations of lipid and amino-acid metabolites

10. Beneficial effects of a screening programme for alcohol-related liver fibrosis with transient elastography in people with alcohol use disorder promoting alcohol abstinence

11. Natural history of hepatic steatosis associated to metabolic syndrome. Longitudinal study with 5 years of follow-up.

12. Prospective evaluation of the EASL clinical guidelines algorithm of management of acute kidney injury in cirrhosis

13. Quality of life in patients with advanced cirrhosis. Relationship with the development of complications

14. Blood metabolomics unveils mitochondrial dysfunction as a potential key feature in the pathogenesis of hepatorenal syndrome

15. Improving NIAAA criteria for the diagnosis of alcoholic hepatitis, role of systemic inflammation

16. STIGMATIZATION IS COMMON IN PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE AND CORRELATES WITH QUALITY OF LIFE

17. Effects of the COVID-19 pandemic on the activity of an advanced practice nurse clinic on liver cirrhosis

18. Alcoholic foamy degeneration: a unique variant of ALD that shows a characteristic pattern of gene expression with upregulation of lipid metabolism and mitochondrial genes and downregulation of fibrosis genes

19. Patterns of kidney dysfunction in acute‐on‐chronic liver failure: Relationship with kidney and patients’ outcome

20. Ammonium quantification in human plasma by proton nuclear magnetic resonance for staging of liver fibrosis in alcohol‐related liver disease and nonalcoholic fatty liver disease

21. Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life

23. FRI-431 - Patients with alcohol-related cirrhosis who recompensate on follow-up have a characteristic metabolomic profile with differential concentrations of lipid and amino-acid metabolites

24. SAT524 - Prospective evaluation of the EASL clinical guidelines algorithm of management of acute kidney injury in cirrhosis

25. SAT522 - Blood metabolomics unveils mitochondrial dysfunction as a potential key feature in the pathogenesis of hepatorenal syndrome

29. THU039 - Alcoholic foamy degeneration: a unique variant of ALD that shows a characteristic pattern of gene expression with upregulation of lipid metabolism and mitochondrial genes and downregulation of fibrosis genes

32. Two-year multidisciplinary follow-up of COVID-19 patients requiring invasive and noninvasive respiratory support.

33. Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life.

Catalog

Books, media, physical & digital resources